54
Views
8
CrossRef citations to date
0
Altmetric
Articles

Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients

, ORCID Icon, , &
Pages 64-69 | Received 24 Jan 2019, Accepted 08 Mar 2019, Published online: 26 Apr 2019

References

  • Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am. 2015;24:1–17.
  • Gomaa AI, Khan SA, Toledano MB, et al. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300.
  • Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–346.
  • Hagen TM, Huang S, Curnutte J, et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1994;91:12808–12812.
  • Friedberg EC. DNA damage and repair. Nature. 2003;421:436–440.
  • Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22–33.
  • Wood RD, Mitchell M, Sgouros J, et al. Human DNA repair genes. Science. 2001;291:1284–1289.
  • Masson M, Niedergang C, Schreiber V, et al. XRCC1 is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18:3563–3571.
  • Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair. 2003;2:955–969.
  • Kirk GD, Turner PC, Gong Y, et al. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev. 2005;14:373–379.
  • Kiran M, Saxena R, Chawla YK, et al. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem. 2009;327:7–13.
  • Pan H-Z, Liang J, Yu Z, et al. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac J Cancer Prev. 2011;12:2947–2950.
  • European Association for the Study of the Liver. EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
  • Yuan Z, Li J, Li J, et al. SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep. 2013;40:7–12.
  • Bi J, Zhong C, Li K, et al. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population. Biomed Res Int. 2013;2013:1–6.
  • Abo El-khair S, Arafa M, Besheer T, et al. The association of XRCC1 gene polymorphisms and chronic hepatitis C induced insulin resistancein Egyptian Patients. Cells. 2018;7:185.
  • Craxi A, Wedemeyer H, Bjoro K, et al.; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol. 2011;55:245–264.
  • Ferguson LR. Chronic inflammation and mutagenesis. Mutat Res. 2010;690:3–11.
  • Thompson LH, Brookman KW, Jones NJ, et al. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol. 1990;10:6160–6171.
  • Basso D, Navaglia F, Fogar P, et al. DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta. 2007;381:50–55.
  • Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med. 2007;28:258–275.
  • Yu H-P, Zhang X-Y, Wang X-L, et al. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev. 2004;28:194–199.
  • Han X, Xing Q, Li Y, et al. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Hepato-gastroenterology. 2012;59:2285–2289.
  • Rossit ARB, Cabral IR, Hackel C, et al. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. Cancer Lett. 2002;180:173–182.
  • Yu M-W, Yang S-Y, Pan I-J, et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B–related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95:1485–1488.
  • Long XD, Ma Y, Huang HD, et al. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China. Mol Carcinog. 2008;47:295–300.
  • Li Q-W, Lu C-R, Ye M, et al. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13:191–194.
  • Liu F, Li B, Wei Y, et al. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta‐analysis. Liver Int. 2011;31:802–809.
  • Nissar S, Sameer AS, Rasool R, et al. DNA repair gene-XRCC1 in relation to genome instability and role in colorectal carcinogenesis. Oncol Res Treat. 2014;37:418–422.
  • Zhang K, Zhou B, Wang Y, et al. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies. Gene. 2012;510:93–101.
  • Sghaier I, Zidi S, Mouelhi L, et al. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection. Br J Biomed Sci. 2019;76:35–41.
  • El-Bendary M, Neamatallah M, Elalfy H, et al. The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection. Br J Biomed Sci. 2018;75:175–181.
  • Attallah A, Omran D, Marie M, et al. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. Br J Biomed Sci. 2018;75:157–162.
  • El-Bendary M, Neamatallah M, Elalfy H, et al. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection. Br J Biomed Sci. 2019;76:11–16.
  • Attallah A, El-Far M, Abdelrazek M, et al. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. Br J Biomed Sci. 2017;74:170–175.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.